
Pharmacist
News
Medicine safety alert - ranitidine (withdrawn)
26 June 2020
Ranitidine products (Brand names including Zantac®) were voluntarily withdrawn by manufacturers in October 2019, because of fears that they may contain low levels of an impurity called NMDA.
News
Medicines safety alert – apraclonidine use in infants below six months of age
17 March 2020
The RCPCH/NPPG Medicines Committee has recently been informed of a severe adverse reaction in a six-month old child with anisocoria who had been administered apraclonidine 1% to help exclude Horner syndrome.
News
Medicines safety alert - domperidone
16 December 2019
Domperidone is no longer licensed for use in children younger than 12 years or those weighing less than 35 kg because of a lack of evidence for benefit.
Resource
Satellite dispensary in the discharge lounge - winter pressures case study
Dr Keir Shiels at a district general hospital describes a measure to tackle delays in discharging patients: a satellite dispensary in a paediatric discharge lounge.
News
RCPCH responds to draft NICE guidance and outcome of NHS England review on CBMPs
13 August 2019
Last week, NICE published draft recommendations on the use of cannabis-based medicinal products (CBMPs) following evaluation of their clinical and cost-effectiveness, and NHS England published a review aimed at assessing the barriers to prescribing cannabis-based medicinal products where it is safe ...
Document
The use of unlicensed medicines or licensed medicines for unlicensed applications in paediatric practice
This statement, originally produced in 2000, was updated in 2013 by the Joint Standing Committee on Medicines, a committee of the Royal College of Paediatrics and Child Health and the Neonatal and Paediatric Pharmacists Group. The update reflects changes in European (including UK) law that aim to fa...
Resource
QI Central – sharing QI experience and expertise
The RCPCH quality improvement sharing hub where you can find resources and examples of interventions in a number of clinical practice areas. Launched in March 2019 and refreshed in October 2020.
Document
Use of delayed prescriptions of antibiotics for infants and children - statement
The aim of this evidence-based statement is to summarise the current knowledge about delayed prescriptions (also called backup prescriptions) for antibiotics and to highlight the special issues that must be taken into account when considering the need for a delayed prescription in infants and childr...
Resource
NPDA Results Online - find your results for the National Paediatric Diabetes Audit
NPDA Results Online was developed in response to consultations with the paediatric diabetes community who told us they wanted to view and compare the results of NPDA unit level summaries in a more accessible way. See below for some tips on how to use it, or download our user guide.
Resource
Professional ethics and law resources
Paediatricians and other clinicians often have to take very difficult decisions while acting in strict accordance with the law and with sensitivity towards the customs and beliefs practiced by their patients and their patients' families. These resources are intended to support the training and crit...